Citigroup Inc. reduced its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 43.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,801 shares of the medical instruments supplier’s stock after selling 4,511 shares during the period. Citigroup Inc.’s holdings in ICU Medical were worth $1,332,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in ICUI. AQR Capital Management LLC increased its holdings in ICU Medical by 566.3% in the third quarter. AQR Capital Management LLC now owns 382,179 shares of the medical instruments supplier’s stock valued at $108,061,000 after buying an additional 324,819 shares during the last quarter. Vanguard Group Inc increased its holdings in ICU Medical by 12.0% in the third quarter. Vanguard Group Inc now owns 1,483,501 shares of the medical instruments supplier’s stock valued at $419,459,000 after buying an additional 158,798 shares during the last quarter. Vanguard Group Inc. increased its holdings in ICU Medical by 12.0% in the third quarter. Vanguard Group Inc. now owns 1,483,501 shares of the medical instruments supplier’s stock valued at $419,459,000 after buying an additional 158,798 shares during the last quarter. Marshall Wace LLP purchased a new position in ICU Medical in the third quarter valued at $43,334,000. Finally, TIAA CREF Investment Management LLC increased its holdings in ICU Medical by 230.8% in the third quarter. TIAA CREF Investment Management LLC now owns 165,570 shares of the medical instruments supplier’s stock valued at $46,815,000 after buying an additional 115,526 shares during the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.
Several research firms recently commented on ICUI. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, February 20th. Raymond James dropped their target price on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a report on Friday, March 1st. Finally, Zacks Investment Research lowered ICU Medical from a “hold” rating to a “sell” rating in a report on Friday, January 4th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. ICU Medical presently has a consensus rating of “Buy” and an average price target of $281.00.
In other ICU Medical news, VP Virginia Ruth Sanzone sold 5,277 shares of the firm’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $232.31, for a total transaction of $1,225,899.87. Following the transaction, the vice president now owns 13,167 shares of the company’s stock, valued at $3,058,825.77. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 1,500 shares of the firm’s stock in a transaction dated Monday, January 28th. The stock was sold at an average price of $242.19, for a total value of $363,285.00. Following the transaction, the director now directly owns 19,540 shares in the company, valued at approximately $4,732,392.60. The disclosure for this sale can be found here. Company insiders own 12.50% of the company’s stock.
NASDAQ:ICUI opened at $232.85 on Friday. The firm has a market capitalization of $4.77 billion, a P/E ratio of 30.20 and a beta of 0.75. ICU Medical, Incorporated has a 12 month low of $210.94 and a 12 month high of $321.70.
COPYRIGHT VIOLATION NOTICE: This report was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.americanbankingnews.com/2019/03/17/citigroup-inc-has-1-33-million-stake-in-icu-medical-incorporated-icui.html.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: How is an ETF different from a mutual fund?
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.